Suppr超能文献

作为氟喹诺酮对分枝杆菌效力衡量指标的突变预防浓度

Mutant prevention concentration as a measure of fluoroquinolone potency against mycobacteria.

作者信息

Sindelar G, Zhao X, Liew A, Dong Y, Lu T, Zhou J, Domagala J, Drlica K

机构信息

Public Health Research Institute, New York, New York 10016, USA.

出版信息

Antimicrob Agents Chemother. 2000 Dec;44(12):3337-43. doi: 10.1128/AAC.44.12.3337-3343.2000.

Abstract

Mutant prevention concentration (MPC) has been proposed as a new measure of antibiotic potency by which the ability to restrict selection of resistant mutants is evaluated. To determine whether MPC provides potency information unavailable from the more customary measurement of the MIC, 18 fluoroquinolones were examined for their ability to block the growth of Mycobacterium smegmatis and to select resistant mutants from wild-type populations. Both MPC and MIC were affected by changes in the moiety at the fluoroquinolone C-8 position and in alkyl groups attached to the C-7 piperazinyl ring. When eight resistant mutants, altered in the gyrase A protein, were tested with fluoroquinolones having either a methoxy or a hydrogen at the C-8 position, the MIC for the most resistant mutant correlated better with the MPC than did the MIC for wild-type cells. For C-8-fluorine derivatives, which were generally less active than the C-8-methoxy compounds but which were more active than C-8-hydrogen derivatives, the MICs for both the mutant and the wild type correlated well with the MPCs. Thus, measurement of the MICs for wild-type cells can reflect the ability of a quinolone to restrict the selection of resistance, but often it does not. With the present series of compounds, the most potent contained a C-8-methoxy and a small group attached to the C-7 ring.

摘要

突变预防浓度(MPC)已被提议作为评估抗生素效力的一项新指标,通过该指标可评估限制耐药突变体选择的能力。为确定MPC是否能提供从更常用的最低抑菌浓度(MIC)测量中无法获得的效力信息,对18种氟喹诺酮类药物抑制耻垢分枝杆菌生长以及从野生型群体中选择耐药突变体的能力进行了研究。MPC和MIC均受氟喹诺酮C-8位部分以及连接在C-7哌嗪环上的烷基变化的影响。当用C-8位为甲氧基或氢的氟喹诺酮类药物对8种在gyrase A蛋白上发生改变的耐药突变体进行测试时,最耐药突变体的MIC与MPC的相关性比野生型细胞的MIC更好。对于C-8氟衍生物,其活性通常低于C-8甲氧基化合物,但高于C-8氢衍生物,突变体和野生型的MIC与MPC均具有良好的相关性。因此,测量野生型细胞的MIC可以反映喹诺酮类药物限制耐药性选择的能力,但通常并非如此。在本系列化合物中,效力最强的含有C-8甲氧基和连接在C-7环上的一个小基团。

相似文献

1
Mutant prevention concentration as a measure of fluoroquinolone potency against mycobacteria.
Antimicrob Agents Chemother. 2000 Dec;44(12):3337-43. doi: 10.1128/AAC.44.12.3337-3343.2000.
5
Selection of antibiotic-resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations.
J Infect Dis. 2000 Aug;182(2):517-25. doi: 10.1086/315708. Epub 2000 Jul 24.
6
Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra.
Antimicrob Agents Chemother. 1996 Aug;40(8):1768-74. doi: 10.1128/AAC.40.8.1768.

引用本文的文献

2
Bifidobacterium adolescentis is intrinsically resistant to antitubercular drugs.
Sci Rep. 2018 Aug 9;8(1):11897. doi: 10.1038/s41598-018-30429-2.
4
5
Moxifloxacin's Limited Efficacy in the Hollow-Fiber Model of Mycobacterium abscessus Disease.
Antimicrob Agents Chemother. 2016 May 23;60(6):3779-85. doi: 10.1128/AAC.02821-15. Print 2016 Jun.
6
Suppression of gyrase-mediated resistance by C7 aryl fluoroquinolones.
Nucleic Acids Res. 2016 Apr 20;44(7):3304-16. doi: 10.1093/nar/gkw161. Epub 2016 Mar 16.
7
Crystal structure and stability of gyrase-fluoroquinolone cleaved complexes from Mycobacterium tuberculosis.
Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1706-13. doi: 10.1073/pnas.1525047113. Epub 2016 Jan 20.
8
Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 1.
Antimicrob Agents Chemother. 2015 Dec 28;60(3):1183-93. doi: 10.1128/AAC.02177-15.
9
Is selection relevant in the evolutionary emergence of drug resistance?
Trends Microbiol. 2015 Mar;23(3):126-33. doi: 10.1016/j.tim.2015.01.005. Epub 2015 Feb 11.

本文引用的文献

1
Mutant prevention concentration as a measure of antibiotic potency: studies with clinical isolates of Mycobacterium tuberculosis.
Antimicrob Agents Chemother. 2000 Sep;44(9):2581-4. doi: 10.1128/AAC.44.9.2581-2584.2000.
2
Selection of antibiotic-resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations.
J Infect Dis. 2000 Aug;182(2):517-25. doi: 10.1086/315708. Epub 2000 Jul 24.
5
Fluoroquinolone action against mycobacteria: effects of C-8 substituents on growth, survival, and resistance.
Antimicrob Agents Chemother. 1998 Nov;42(11):2978-84. doi: 10.1128/AAC.42.11.2978.
7
Crystal structure of the breakage-reunion domain of DNA gyrase.
Nature. 1997 Aug 28;388(6645):903-6. doi: 10.1038/42294.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验